Eftilagimod Alpha Novel Triplet Combination is Well Tolerated, Generates CRs in Soft Tissue Sarcoma
Eftilagimod alpha plus radiotherapy and pembrolizumab was safe and displayed initial activity in soft tissue sarcoma.
Source: onclive.com
Soft Tissue Sarcoma News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Soft Tissue Sarcoma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Soft Tissue Sarcoma Today - Breaking & Trending Today
Study Sees Limited Success for Extrapleural Pneumonectomy in Sarcoma Cases
In this retrospective analysis, outcomes data were evaluated on patients receiving care related to extrapleural pneumonectomy for soft tissue sarcoma or bone sarcoma.
Source: ajmc.com
Nirogacestat Linked With Improved Functional Status in Patients With Desmoid Tumors
Results presented at the National Community Oncology Dispensing Association International Spring Forum describe meaningful improvements in functioning among patients who received the oral gamma secretase inhibitor to treat progressing desmoid tumors.
Source: ajmc.com
Soft Tissue Sarcoma - Types, Causes, Symptoms, Diagnosis, Treatment & Prevention
Soft tissue sarcoma is a rare cancer of connective tissue that can affect soft tissues such as fat, muscle, nerves and blood vessels of any body part.
Source: medindia.net
FDA Grants Orphan Drug Designation to Tigilanol Tiglate in Soft Tissue Sarcoma
The FDA has granted an orphan drug designation to tigilanol tiglate for the treatment of patients with soft tissue sarcoma.
Source: onclive.com